Halaven PI
Aloxi PI
Embrace
All things Eisai
Wild Card
100
40 hours
What is Halaven's half life
100
0.25
What is the lowest effective dose of Aloxi
100
An anthracycline and a taxane
What are what patients in the Embrace study were required to have been treated with previously.
100
HHC
What is Eisai's human health care mission
100
True or false, Aloxi inhibits the tumor activity of the following agents: cisplatin, cyclophosphamide, and doxorubicin.
What is False
200
ANC < 1000 Plateltes < 75,000 Grade 3/4 Heme toxicities
What is "Do not adminster Halaven on day 1 or Day 8 if any of the following are present."
200
30 minutes prior to Chemo
What is when Aloxi should be given
200
At least 2 but not more than 5
What are the number of prior Chemotherapy regimines to qualify for Embrace?
200
number of days annually allotted for HHC activities in the field.
What is 3
200
The web site where you find the most current sales rankings (Nightingale and Pinnacle)
What is Performance Zone
300
0.81
What is the Hazard ratio in the Halaven trial
300
Patients known to have a hypersensitivity to the drug or any of it's components
What is the population in which Aloxi is contraindicated
300
13.3%
What is the % of adverse events that led to discontinuation of the Eribulin group in Embrace
300
Anne O'neill and Stephanie Marsch
Who are the fleet / vehicle team.
300
26.2 with Donna "The Donna Run"
What is one of Eisai Oncology's national HHC events held in February
400
Febrile Neutropenia and Neutropenia
What were the two most common Serious Adverse Events with Halaven
400
cisplatin
What was the HEC regimine that was adminstered to the majority of patients in the dose ranging study.
400
treatment of physicians choice
What was the "comparator" in the Embrace study
400
VP of Oncology Sales and Marketing
Who is David Trexler
400
Name three of the five major categories associated with the Eisai Values:
What are Integrity, Respect, Professionalism, teamwork and quality
500
508
What is the number of intent to treat patients in the Halaven arm.
500
59%
What was the CRR in the Aloxi vs Ondansetron (HEC) study during the acute phase
500
13.12 months
What is the medial OS among patients receiving Eribulin in the Embrace trial.
500
Name 3 of the 7 Eisai field sales representative competencies
What is Embraces and sells the vision Supports innovation and Change Promotes accountability Drives for results Leverages Business acumen Focuses on Customers and business partners Sells effectively
500
Name 3 Regional Field Trainers in Oncology
Who are Dereck Bergquist Kimberly Sandru Chris Aanerud Gordon Burkette Kathy Byrne Paul Landes Mark Meltzer Henry Lovette Jenny Lucksinger
M
e
n
u